CytRx Announces Publication of Phase 1b/2 Aldoxorubicin Clinical Data In Soft Tissue Sarcoma In Cancer, The Peer-Reviewed Journal Of The American Cancer Society
October 20, 2014 at 06:04 AM EDT
CytRx Corporation (CYTR), a biopharmaceutical research and development company specializing in oncology, today announced that a ...